COOL - PolarityTE, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

PolarityTE, Inc.

615 Arapeen Drive
Suite 102
Salt Lake City, UT 84108
United States
732-225-8910
http://www.polarityte.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees33

Key Executives

NameTitlePayExercisedYear Born
Mr. John StetsonCFO, Exec. VP, Sec. & Director151.38kN/A1985
Dr. Denver Lough M.D., Ph.D.Chairman, CEO & Chief Scientific OfficerN/AN/A1981
Dr. Edward Winslow Swanson M.D.COO & DirectorN/AN/A1985
Mr. Cameron J. Hoyler J.D.Gen. CounselN/AN/A1984
Ms. Holly KramenChief Compliance Officer & Privacy OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PolarityTE, Inc. operates as commercial-stage biotechnology and regenerative biomaterials company in the United States. The company focuses on discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its PolarityTE platform would be able to provide transform tissue regeneration, including potential regeneration of multiple tissue substrates, such as skin, bone, muscle, fat, cartilage, nerves, and blood vessels, as well as neural elements, solid and hollow organ composite tissue systems. The company is headquartered in Salt Lake City, Utah.

Corporate Governance

PolarityTE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.